Condition: Overweight · Obesity · Sponsor: Eli Lilly and Company
The main purpose of this study, performed under the master protocol W8M-MC-CWMM (NCT06143956), is to examine the body weight-lowering efficacy and safety of macupatide plus eloralintide compared with placebo in participants with obesity or overweight and without type 2 diabetes. Participation will last about 64 weeks.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| The Institute for Liver Health II dba Arizona Clinical Trials - Mesa | Chandler, Arizona, United States | Recruiting |
| Headlands Research - Scottsdale | Scottsdale, Arizona, United States | Recruiting |
| The Institute for Liver Health II dba Arizona Liver Health-Tucson | Tucson, Arizona, United States | Recruiting |
| NorCal Medical Research, Inc | Greenbrae, California, United States | Recruiting |
| Velocity Clinical Research, Huntington Park | Huntington Park, California, United States | Recruiting |
| Peninsula Research Associates | Rolling Hills Estates, California, United States | Recruiting |
| Diablo Clinical Research, Inc. | Walnut Creek, California, United States | Recruiting |
| Stamford Therapeutics Consortium | Stamford, Connecticut, United States | Recruiting |
| New Horizon Research Center | Miami, Florida, United States | Recruiting |
| Indago Research & Health Center, Inc | Miami Lakes, Florida, United States | Recruiting |
| Suncoast Clinical Research, Inc. | New Port Richey, Florida, United States | Recruiting |
| Charter Research - Winter Park | Orlando, Florida, United States | Recruiting |
+ 28 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07589608